B5KL28 AF NFT

Kunitz-type serine protease inhibitor microlepidin-4

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihieuy75nqxuy3k66pfzygu5tc7ij7jfvych3a6ny722og4a44fae/metadata.json
IPFS of structure file: 
bafybeifefzeojg67xguk3hwnlfq3qm5ckc3nabo75v2qdf3auow7m4f47e/AF-B5KL28-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x35cE46a4a30196447966Bd34E1e090Eb6D1bAd3f
First NFT owner address (bech32): 
genesis1xh8ydf9rqxtyg7txh56wrcysadk3htflk6s798
Current NFT ID #496892 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
496892
Accession (UniProt):
B5KL28
Name::
Kunitz-type serine protease inhibitor microlepidin-4
Experimental Method:
Predicted structure
Sequence source:
Oxyuranus microlepidotus

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B5KL28 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B5KL28|VKT4_OXYMI Kunitz-type serine protease inhibitor microlepidin-4 OS=Oxyuranus microlepidotus OX=111177 PE=2 SV=1 MSSGGLLLLLGLLTLWEVLTPVSSKDRPKFCELPADIGPCEDFTGAFHYSPREHECIEFIYGGCEGNANNFNTLEGCESACAA